{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:26:16Z","timestamp":1774578376393,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf02221685","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T09:32:37Z","timestamp":1128591157000},"page":"1080-1086","source":"Crossref","is-referenced-by-count":18,"title":["Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with Type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets"],"prefix":"10.1007","volume":"35","author":[{"name":"Belgian Diabetes Registry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. K.","family":"Gorus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. -C.","family":"Sodoyez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"Pipeleers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Keymeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Foriers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. F. H.","family":"Van Schravendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02221685_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00274217","volume":"30","author":"DW Drell","year":"1987","unstructured":"Drell DW, Notkins AL (1987) Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132\u2013143","journal-title":"Diabetologia"},{"key":"BF02221685_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/dmr.5610070204","volume":"7","author":"TJ Wilkin","year":"1991","unstructured":"Wilkin TJ (1991) Autoantibodies as mechanisms, markers, and mediators of B-cell disease. Diabetes Metab Rev 7: 105\u2013120","journal-title":"Diabetes Metab Rev"},{"key":"BF02221685_CR3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diab.37.12.1591","volume":"37","author":"NK Maclaren","year":"1988","unstructured":"Maclaren NK (1988) How, when and why to predict IDDM. Diabetes 37: 1591\u20131594","journal-title":"Diabetes"},{"key":"BF02221685_CR4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(88)91601-7","volume":"I","author":"AC Tarn","year":"1988","unstructured":"Tarn AC, Thomas JM, Dean BM et al. (1988) Predicting insulin-dependent diabetes. Lancet I: 845\u2013850","journal-title":"Lancet"},{"key":"BF02221685_CR5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(89)92383-0","volume":"I","author":"GJ Bruining","year":"1989","unstructured":"Bruining GJ, Molenaar JL, Grobbe DE et al. (1989) Ten year follow-up study of islet cell antibodies and childhood diabetes mellitus. Lancet I: 1100\u20131103","journal-title":"Lancet"},{"key":"BF02221685_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0140-6736(90)90013-U","volume":"335","author":"E Bonifacio","year":"1990","unstructured":"Bonifacio E, Bingley PJ, Shattock M et al. (1990) Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147\u2013149","journal-title":"Lancet"},{"key":"BF02221685_CR7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.6362005","volume":"222","author":"JP Palmer","year":"1983","unstructured":"Palmer JP, Asplin CM, Clemons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337\u20131339","journal-title":"Science"},{"key":"BF02221685_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/347151a0","volume":"347","author":"S Baekkeskov","year":"1990","unstructured":"Baekkeskov S, Aanstoot H-J, Christgau S et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151\u2013156","journal-title":"Nature"},{"key":"BF02221685_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF00401206","volume":"35","author":"MR Christie","year":"1992","unstructured":"Christie MR, Brown TJ, Cassidy D (1992) Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35: 380\u2013384","journal-title":"Diabetologia"},{"key":"BF02221685_CR10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2337\/diab.37.1.130","volume":"37","author":"B Kuglin","year":"1988","unstructured":"Kuglin B, Gries FR, Kolb H (1988) Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 37: 130\u2013132","journal-title":"Diabetes"},{"key":"BF02221685_CR11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/diab.35.5.620","volume":"35","author":"J Karjalainen","year":"1986","unstructured":"Karjalainen J, Knip M, Mutsonen A, Ilonen J, \u00c5kerblom HK (1986) Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 35: 620\u2013622","journal-title":"Diabetes"},{"key":"BF02221685_CR12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF00278746","volume":"31","author":"J Ludvigsson","year":"1988","unstructured":"Ludvigsson J, Binder C, Mandrup-Poulsen T (1988) Insulin autoantibodies are associated with islet cell antibodies: their relation to insulin antibodies and B-cell function in diabetic children. Diabetologia 31: 647\u2013651","journal-title":"Diabetologia"},{"key":"BF02221685_CR13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00274776","volume":"31","author":"Ch Thivolet","year":"1988","unstructured":"Thivolet Ch, Beaufr\u00e8re B, B\u00e9tuel H et al. (1988) Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study. Diabetologia 31: 741\u2013746","journal-title":"Diabetologia"},{"key":"BF02221685_CR14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/diab.38.10.1320","volume":"38","author":"AG Ziegler","year":"1989","unstructured":"Ziegler AG, Ziegler R, Vardi P et al. (1989) Life table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38: 1320\u20131325","journal-title":"Diabetes"},{"key":"BF02221685_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0167-4889(89)90220-6","volume":"1014","author":"GJS Cooper","year":"1989","unstructured":"Cooper GJS, Day AJ, Willis AC, Roberts AN, Raid KBM, Leighton B (1989) Amylin and the amylin genes: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta 1014: 247\u2013258","journal-title":"Biochim Biophys Acta"},{"key":"BF02221685_CR16","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/S0021-9258(19)39539-0","volume":"265","author":"M Nishi","year":"1990","unstructured":"Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF (1990) Islet amyloid polypeptide. A new \u03b2-cell secretory product related to islet amyloid deposits. J Biol Chem 265: 4173\u20134176","journal-title":"J Biol Chem"},{"key":"BF02221685_CR17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/diab.40.3.310","volume":"40","author":"KH Johnson","year":"1991","unstructured":"Johnson KH, O'Brien TD, Westermark P (1991) Newly identified pancreatic protein islet amyloid polypeptide: what is its relationship to diabetes? Diabetes 40: 310\u2013314","journal-title":"Diabetes"},{"key":"BF02221685_CR18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF00278754","volume":"31","author":"F Sodoyez-Goffaux","year":"1988","unstructured":"Sodoyez-Goffaux F, Koch M, Dozio N, Brandenburg D, Sodoyez JC (1988) Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies. Diabetologia 31: 694\u2013702","journal-title":"Diabetologia"},{"key":"BF02221685_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00586462","volume":"33","author":"JP Palmer","year":"1990","unstructured":"Palmer JP, Wilkin TJ, Kurtz AB, Bonifacio E (1990) The third international workshop on the standardisation of insulin autoantibody measurement. Diabetologia 33: 60\u201361","journal-title":"Diabetologia"},{"key":"BF02221685_CR20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00400213","volume":"33","author":"B Kuglin","year":"1990","unstructured":"Kuglin B, Kolb H, Greenbaum C, Maclaren NK, Lernmark \u00c5, Palmer JP (1990) The fourth international workshop on the standardisation of insulin autoantibody measurement. Diabetologia 33: 638\u2013639","journal-title":"Diabetologia"},{"key":"BF02221685_CR21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diacare.14.1.61","volume":"14","author":"C L\u00e9vy-Marchal","year":"1991","unstructured":"L\u00e9vy-Marchal C, Bridel MP, Sodoyez-Goffaux F et al. (1991) Superiority of radiobinding assay over enzyme-linked immunosorbent assay for detection of insulin autoantibodies in newly diagnosed type 1 diabetic patients. Diabetes Care 14: 61\u201363","journal-title":"Diabetes Care"},{"key":"BF02221685_CR22","first-page":"1040","volume":"74","author":"C Greenbaum","year":"1992","unstructured":"Greenbaum C, Palmer JP, Kuglin B, Kolb H and participating laboratories (1992) Insulin autoantibodies measured by R1A methodology are more related to IDDM than those measured by ELISA. J Clin Endocrinol Metab 74: 1040\u20131044","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02221685_CR23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0167-5699(88)91333-3","volume":"9","author":"R Dziarski","year":"1988","unstructured":"Dziarski R (1988) Autoimmunity: polyclonal activation or antigen induction? Immunol Today 9: 340\u2013342","journal-title":"Immunol Today"},{"key":"BF02221685_CR24","first-page":"141","volume":"1","author":"Y Tomer","year":"1988","unstructured":"Tomer Y, Shoenfeld Y (1988) Ageing and autoantibodies. Auto-immunity 1: 141\u2013149","journal-title":"Auto-immunity"},{"key":"BF02221685_CR25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/clinchem\/37.3.430","volume":"37","author":"M Laureys","year":"1991","unstructured":"Laureys M, Sion JP, Slabbynck H et al. (1991) Macrocreatine kinase type 1: a serum marker associated with disease. Clin Chem 37: 430\u2013434","journal-title":"Clin Chem"},{"key":"BF02221685_CR26","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/clinchem\/38.9.1762","volume":"38","author":"T Decraene","year":"1992","unstructured":"Decraene T, Vandewalle C, Pipeleers DG, Gorus FK and the Belgian Diabetes Registry (1992) Elevated IgM concentrations at onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. Clin Chem 38: 1762\u20131769","journal-title":"Clin Chem"},{"key":"BF02221685_CR27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","volume":"28","author":"National Diabetes Data Group","year":"1979","unstructured":"National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039\u20131057","journal-title":"Diabetes"},{"key":"BF02221685_CR28","volume-title":"Insulin autoantibodies in newly diagnosed insulin-dependent diabetic patients","author":"WP Tan","year":"1990","unstructured":"Tan WP (1990) Insulin autoantibodies in newly diagnosed insulin-dependent diabetic patients. M. Sc. thesis, Vrije Universiteit Brussel, Brussels"},{"key":"BF02221685_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2337\/diab.35.2.139","volume":"35","author":"S Srikanta","year":"1986","unstructured":"Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP (1986) Autoimmunity to insulin, beta cell dysfunction and development of insulin-dependent diabetes mellitus. Diabetes 35: 139\u2013142","journal-title":"Diabetes"},{"key":"BF02221685_CR30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/endo-117-3-841","volume":"117","author":"CFH Schravendijk Van","year":"1985","unstructured":"Van Schravendijk CFH, Foriers A, Hooghe-Peters EL et al. (1985) Pancreatic hormone receptors on islet cells. Endocrinology 117: 841\u2013848","journal-title":"Endocrinology"},{"key":"BF02221685_CR31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-291X(89)91732-4","volume":"164","author":"M Nakazato","year":"1989","unstructured":"Nakazato M, Asai J, Kangawa K, Matsukura S, Matsuo H (1989) Establishment of a radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem Biophys Res Commun 164: 394\u2013399","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02221685_CR32","first-page":"255","volume":"17","author":"JC Sodoyez","year":"1991","unstructured":"Sodoyez JC, Koch M, Sodoyez-Goffaux F (1991) Anticorps anti-insuline: methodologie et implications cliniques. Diab\u00e8te M\u00e9tab 17: 255\u2013269","journal-title":"Diab\u00e8te M\u00e9tab"},{"key":"BF02221685_CR33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","volume":"II","author":"GF Bottazzo","year":"1974","unstructured":"Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet II: 1279\u20131283","journal-title":"Lancet"},{"key":"BF02221685_CR34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF00400345","volume":"33","author":"E Bonifacio","year":"1990","unstructured":"Bonifacio E, Boitard C, Gleichmann H et al. (1990) Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 33: 731\u2013736","journal-title":"Diabetologia"},{"key":"BF02221685_CR35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF00276847","volume":"31","author":"J Karjalainen","year":"1988","unstructured":"Karjalainen J, Knip M, Hy\u00f6ty H et al. (1988) Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes. Diabetologia 31: 146\u2013152","journal-title":"Diabetologia"},{"key":"BF02221685_CR36","first-page":"1320","volume":"11","author":"P Vardi","year":"1989","unstructured":"Vardi P, Ziegler AG, Mathews JH et al. (1989) Concentration of insulin autoantibodies at onset of type 1 diabetes. Diabetes Care 11: 1320\u20131325","journal-title":"Diabetes Care"},{"key":"BF02221685_CR37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/jcem-73-6-1197","volume":"73","author":"L Casta\u00f1o","year":"1991","unstructured":"Casta\u00f1o L, Russo E, Zhou L, Lipes MA, Eisenbarth GS (1991) Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type 1 diabetes. J Clin Endocrinol Metab 73: 1197\u20131201","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02221685_CR38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1464-5491.1991.tb01675.x","volume":"8","author":"A Clark","year":"1991","unstructured":"Clark A, Yon SM, de Koning EJP, Holman RK (1991) Autoantibodies to islet amyloid polypeptide in diabetes. Diabetic Med 8: 668\u2013673","journal-title":"Diabetic Med"},{"key":"BF02221685_CR39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00403281","volume":"34","author":"JC Sodoyez","year":"1991","unstructured":"Sodoyez JC, Koch M, Lemaire I et al. (1991) Influence of affinity of antibodies upon their detection by liquid phase radiobinding assay and solid phase enzyme linked immunosorbent assay. Demonstration using monoclonal antibodies raised against rDNA human proinsulin. Diabetologia 34: 463\u2013468","journal-title":"Diabetologia"},{"key":"BF02221685_CR40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0167-5699(85)90093-3","volume":"6","author":"D Holmberg","year":"1985","unstructured":"Holmberg D, Coutinho A (1985) Natural antibodies and autoimmunity. Immunol Today 6: 356\u2013357","journal-title":"Immunol Today"},{"key":"BF02221685_CR41","first-page":"128","volume-title":"Basic and clinical immunology","author":"AN Theofilopoulos","year":"1987","unstructured":"Theofilopoulos AN (1987) Autoimmunity. In: Stiter DP, Stobo JD, Wells JU (eds) Basic and clinical immunology. 6th edn. Appleton & Lange, Norwalk, pp 128\u2013158","edition":"6th edn."},{"key":"BF02221685_CR42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.iy.03.040185.002441","volume":"3","author":"JA Tamer","year":"1985","unstructured":"Tamer JA, Getzoff ED, Paterson Y, Olson AJ, Lerner RA (1985) The atomic mobility component of protein antigenicity. Ann Rev Immunol 3: 501\u2013535","journal-title":"Ann Rev Immunol"},{"key":"BF02221685_CR43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/322747a0","volume":"322","author":"PJ Barlow","year":"1986","unstructured":"Barlow PJ, Edwards MS, Thornton JM (1986) Continuous and discontinuous protein antigenic determinants. Nature 322: 747\u2013748","journal-title":"Nature"},{"key":"BF02221685_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/311123a0","volume":"311","author":"E Westhof","year":"1984","unstructured":"Westhof E, Altschuk D, Moras D et al. (1984) Correlation between segmental mobility and the location of antigenic determinants in protein. Nature 311: 123\u2013126","journal-title":"Nature"},{"key":"BF02221685_CR45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/diab.37.3.276","volume":"37","author":"SE Fineberg","year":"1988","unstructured":"Fineberg SE, Rathbun MJ, Hufferd S et al. (1988) Immunologic aspects of human proinsulin therapy. Diabetes 37: 276\u2013280","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02221685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02221685\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02221685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T10:12:42Z","timestamp":1626603162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02221685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF02221685"],"URL":"https:\/\/doi.org\/10.1007\/bf02221685","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]}}}